Colorectal Surgery with Transanal Excision procedure is an option for patients needing colon or rectal removal. In this procedure, the surgeon removes the colon or rectum and the surrounding tissue ...

Individuals with IBD undergoing colectomy may benefit from surveillance for kidney function. Patients with inflammatory bowel disease (IBD) undergoing colectomy have higher rates of acute kidney ...

Dear Doctors: My husband is 78 years old. A second colectomy left him with one-fourth of his colon, and he suffers from chronic diarrhea. I’ve read that he should avoid sugar and alcohol, which he won ...

Dear Doctors: My husband is 78 years old. A second colectomy left him with one-fourth of his colon, and he suffers from chronic diarrhea. I’ve read that he should avoid sugar and alcohol, which he won ...

A new clinical practice update from the American Gastroenterological Association recommends that clinicians treating refractory constipation perform comprehensive physiologic and psychological ...

12% of people with ulcerative colitis need surgery to have their colon removed (colectomy). Most of those have an ileo-anal pouch surgically constructed from their small bowel, which means that they ...

Fecal microbiota transplantation (FMT) has emerged as a highly successful therapeutic strategy for recurrent Clostridioides difficile infection (CDI) in recent years. However, “implementation of FMT ...

Most people with colon cancer begin treatment by having surgery to remove their cancer. If colon cancer has spread beyond your colon, you might have chemotherapy first. This can help treat cancer ...

A decade-long national audit of total abdominal colectomy (TAC) for ulcerative colitis in the Republic of Ireland showed no 30-day mortality and an increased adoption of laparoscopy and identified ...

For the 907,000 Americans with ulcerative colitis, living with symptoms like urgent bowel movements, abdominal cramps, and loose or bloody stools can be overwhelming, but treatments can help keep ...

Response to the combination of cetuximab, bevacizumab and irinotecan (cetux/bev/iri) in patients (pts) previously treated with 3rd-line panitumumab, following disease progression on oxaliplatin, ...